|
|

Technical
Example
The
table(1) below illustrates how the amino acid test provides
evidence for paleoDNA preservation.
The
table shows 26 individuals (human and animal), their radiocarbon ages, the
results of the amino acid test, and the success in obtaining paleoDNA.
The
primary indicator of the amino acid test is the "racemization"
result for Aspartic acid (one of the most abundant amino acids in bone).
Racemization is the transference of the L-enantiomer to the D-enantiomer,
which occurs during diagenesis. In simple terms, "enantiomer"
is the coiling direction of the helical shape of the amino acid molecule.
The "L" enantiomer coils to the left. With diagenesis, there is
a systematic change to the right-handed "D" enantiomer. Aspartic
acid starts as entirely the L type (as do all amino acids). The
transference from one direction to the other is called "racemization".
Amino acid racemization has long been investigated as a dating tool (with
limited success).
Recent
investigations into the application of this process (Poinar, et. al.)(1)
have shown a correlation between the D/L ratio of Aspartic acid and
the preservation of paleoDNA. Results of this work are tabulated
below. Notice that samples with Aspartic acid D/L ratios (D/L Asp)
of 0.10 or less, contained paleoDNA and those with values greater than 0.10
did not.
Other
ratios are reported in the table as well. On-going research suggests
that the relative racemization of Aspartic acid to Alanine to Leucine may
be an indicator of any available paleoDNA. Amino acids
which are primary to the bone should show a decreasing trend in
racemization from Aspartic acid to Alanine to Leucine. If this trend
is present, it is evidence that any paleoDNA detected is primary to the
individual. A different pattern may indicate the presence of
exogenous carbon (and potentially exogenous DNA) in the analyzed material.
More research is needed before making broad assumptions on
this phenomenon. The racemization of both Alanine and Leucine is
usually extremely low, circumventing its application.
CAVEAT:
A low D/L Asp value does not ensure the presence of paleoDNA. It is
an indicator. However, no paleoDNA has been retrieved from samples
with a ratio of greater than 0.20.
___________________
Table
1. (1) The extent of racemization of Asp, Ala, and Leu and DNA amplificability for
26 archaeological and paleontological samples. DNA was extracted, amplified, and
sequenced as described in the references. Briefly, for nonhuman samples 140 bp
of the mitochondrial 16S ribosomal DNA (rDNA), or 120 bp of the mitochondrial
12S rDNA, were amplified, whereas for human samples primers for an 87-bp
fragment of the mitochondrial control region were used. In all cases in which no
DNA could be amplified, extractions were performed as in (18) and at least two
attempts were made under conditions allowing amplification from single template
molecules.
|
Sample |
Age (years ago) |
D/L
Asp |
D/L
Ala |
D/L
Leu |
DNA (bp) |
Reference |
|
Equus
sp. (California) |
50 |
0.05 |
0.01 |
0.00 |
340 |
|
|
Mylodon
darwinii (Chile) |
13,000 |
0.05 |
0.00 |
0.01 |
140 |
(5) |
|
Mammuthus
primigenius (Yuribei, Siberia) |
9,700 |
0.05 |
0.00 |
0.00 |
200 |
(8) |
|
Equus
ferus (Siberia) |
42,000 |
0.06 |
0.01 |
0.01 |
140 |
|
|
M.
primigenius (Khatanga, Siberia) |
50,000 |
0.06 |
0.01 |
0.00 |
200 |
(8) |
|
M.
primigenius (Shandrin, Siberia) |
35-40,000 |
0.06 |
0.01 |
0.00 |
200 |
(8) |
|
E.
hemionus (Alaska) |
27,000 |
0.07 |
0.01 |
0.00 |
140 |
(18) |
|
Mylodon
darwinii (Chile) |
13,000 |
0.07 |
0.04 |
0.00 |
140 |
(5) |
|
Aptornis
sp. (New Zealand) |
3,000 |
0.08 |
0.01 |
0.00 |
120 |
(19) |
|
Bos
primigenius (Europe) |
6,500 |
0.11 |
0.12 |
0.11 |
0 |
|
|
E. ferus
(Germany) |
5,500 |
0.15 |
0.00 |
0.00 |
0 |
|
|
Nothrotherium
shastense (New Mexico) |
13,000 |
0.17 |
0.01 |
0.00 |
0 |
|
|
Papio
cf. cynocephalus (Egypt) |
2,300 |
0.18 |
0.02 |
0.00 |
0 |
|
|
E.
caballus (Chile) |
20,000 |
0.20 |
0.25 |
0.00 |
0 |
|
|
Human
femur (Egypt) |
4,500 |
0.21 |
0.02 |
0.00 |
0 |
|
|
Megalonyx
(Florida) |
13,000 |
0.24 |
0.85 |
0.00 |
0 |
|
|
Human
femur (Egypt) |
4,500 |
0.29 |
0.01 |
0.00 |
0 |
|
|
Human
femur (Egypt) |
4,500 |
0.29 |
0.12 |
0.00 |
0 |
|
|
Human
femur (Egypt) |
4,500 |
0.30 |
0.00 |
0.00 |
0 |
|
|
Human
femur (Egypt) |
4,500 |
0.31 |
0.02 |
0.00 |
0 |
|
|
Megalonyx
sp. (Florida) (tooth) |
13,000 |
0.33 |
0.44 |
0.23 |
0 |
|
|
Glossotherium
sp. (Cuba) |
15,000 |
0.34 |
0.29 |
0.01 |
0 |
|
|
Acratocnus
odontrigonus (Puerto Rico) |
15,000 |
0.49 |
0.61 |
0.15 |
0 |
|
|
Scelidon
chiliense (Peru) |
15,000 |
0.51 |
0.81 |
0.15 |
0 |
|
|
Eremotherium
mirable (Peru) |
13,000 |
0.60 |
0.27 |
0.14 |
0 |
|
|
Megalocnus
sp. (La Brea, California) |
15,000 |
0.75 |
0.53 |
0.24 |
0 |
|
(1)
Poinar, Hendrik N., Hoss,
Matthias, Bada, Jeffrey L., Paabo, Svante Amino Acid Racemization and
the Preservation of Ancient DNA Science 1996 272: 864-866
References for
table:
(5) M. Höss, A. Dilling, A.
Currant, S. Pääbo, Proc. Natl. Acad. Sci. U.S.A. 93, 181 (1996)
(8) T. Lindahl, Nature
365, 700
(1993); M. Höss, M.K. Vereshchagin, S. Pääbo, ibid. 370, 333
(1994).
(18) M. Höss and S. Pääbo,
Nuceic Acids Res. 21, 3913 (1993).
(19) A. Cooper and P. Hood,
in Avian Molecular Evolution and Systematics, D. Mindell, Ed. (Academic Press,
New York, in press).
|